COMMONWEALTH EQUITY SERVICES, LLC - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 22 filers reported holding MOLECULIN BIOTECH INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q4 2019$10,000
-23.1%
12,0000.0%0.00%
Q3 2019$13,000
+8.3%
12,000
+20.0%
0.00%
Q2 2019$12,000
-25.0%
10,000
-50.0%
0.00%
Q1 2019$16,000
+60.0%
20,000
+100.0%
0.00%
Q4 2018$10,000
-69.7%
10,000
-52.4%
0.00%
Q3 2018$33,000
-15.4%
21,000
-4.5%
0.00%
Q2 2018$39,000
+34.5%
22,000
+33.3%
0.00%
Q1 2018$29,0000.0%16,500
+7.1%
0.00%
Q4 2017$29,00015,4000.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q1 2020
NameSharesValueWeighting ↓
Whitegate Investment Counselors, Inc. 97,000$155,0000.03%
Laird Norton Wetherby Wealth Management, LLC 19,792$32,0000.00%
Avondale Wealth Management 2,659$4,0000.00%
TRUIST FINANCIAL CORP 90,000$144,0000.00%
OneDigital Investment Advisors LLC 2,800$4,0000.00%
CIBC WORLD MARKET INC. 89,300$143,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 3,778$6,0000.00%
Global Retirement Partners, LLC 1,000$2,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 126,497$202,0000.00%
View complete list of MOLECULIN BIOTECH INC shareholders